Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

BRD7 anticorps (AA 601-651)

BRD7 Reactivité: Humain ELISA, IHC, IF Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7145816
  • Antigène Voir toutes BRD7 Anticorps
    BRD7 (Bromodomain Containing 7 (BRD7))
    Épitope
    • 15
    • 8
    • 7
    • 6
    • 6
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 601-651
    Reactivité
    • 43
    • 34
    • 4
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 50
    • 1
    Lapin
    Clonalité
    • 49
    • 2
    Polyclonal
    Conjugué
    • 17
    • 5
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp BRD7 est non-conjugé
    Application
    • 26
    • 20
    • 13
    • 13
    • 5
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
     Réactivité croisée
    Humain
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human Bromodomain-containing protein 7 protein (601-651AA)
    Isotype
    IgG
    Top Product
    Discover our top product BRD7 Anticorps primaire
  • Indications d'application
    Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    BRD7 (Bromodomain Containing 7 (BRD7))
    Autre désignation
    BRD7 (BRD7 Produits)
    Synonymes
    anticorps zgc:66347, anticorps wu:fc95f02, anticorps MGC79478, anticorps BRD7, anticorps BP75, anticorps CELTIX1, anticorps NAG4, anticorps Ptpn13ip, anticorps bromodomain containing 7 L homeolog, anticorps bromodomain containing 7, anticorps brd7.L, anticorps brd7, anticorps BRD7, anticorps Brd7
    Sujet

    Background: Acts both as coactivator and as corepressor. May play a role in chromatin remodeling. Activator of the Wnt signaling pathway in a DVL1-dependent manner by negatively regulating the GSK3B phosphotransferase activity. Induces dephosphorylation of GSK3B at \\\'Tyr-216\\\'. Down-regulates TRIM24-mediated activation of transcriptional activation by AR (By similarity). Transcriptional corepressor that down-regulates the expression of target genes. Binds to target promoters, leading to increased histone H3 acetylation at \\\'Lys-9\\\' (H3K9ac). Binds to the ESR1 promoter. Recruits BRCA1 and POU2F1 to the ESR1 promoter. Coactivator for TP53-mediated activation of transcription of a set of target genes. Required for TP53-mediated cell-cycle arrest in response to oncogene activation. Promotes acetylation of TP53 at \\\'Lys-382\\\', and thereby promotes efficient recruitment of TP53 to target promoters. Inhibits cell cycle progression from G1 to S phase.

    Aliases: 75 kDa bromodomain protein antibody, BP75 antibody, BRD 7 antibody, BRD7 antibody, BRD7_HUMAN antibody, Bromodomain containing 7 antibody, bromodomain containing protein 7 antibody, Bromodomain-containing protein 7 antibody, CELTIX 1 antibody, CELTIX1 antibody, NAG4 antibody, Protein CELTIX-1 antibody

    UniProt
    Q9NPI1
Vous êtes ici:
Support technique